Необязательная аналитика продукта
С вашего разрешения мы используем ограниченную аналитику с защитой конфиденциальности, чтобы понять, какие исследовательские сценарии работают. Мы не используем рекламные трекеры или запись сеансов. Этот выбор можно изменить в настройках. Прочитайте Политику конфиденциальности.
Alphabet Inc. Class C's published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $4.15T | |
|---|---|---|
| Revenue (ttm) | 445.9B | |
| Net income (ttm) | 244.1B | |
| EPS (ttm) | $19.9 | |
| Shares out | 12.2B | |
| P/E (trailing) | 16.1x | |
| P/E (forward) | 22.1x | |
| Dividend | $0.88 (0.27%) | |
| Volume | 17,944,160 | |
| Beta | 1.21 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $257.64B | $282.84B | $307.39B | $350.02B | $402.84B | +11.8% |
| Gross profit | $146.70B | $156.63B | $174.06B | $203.71B | $240.30B | +13.1% |
| Operating income | $78.71B | $74.84B | $84.29B | $112.39B | $129.04B | +13.2% |
| Net income | $76.03B | $59.97B | $73.80B | $100.12B | $132.17B | +14.8% |
| EPS (diluted) | $5.61 | $4.56 | $5.80 | $8.04 | $10.81 | +17.8% |
| EBITDA | $103.52B | $85.16B | $97.97B | $135.39B | $180.70B | +14.9% |
| R&D | $31.56B | $39.50B | $45.43B | $49.33B | $61.09B | +17.9% |
| SG&A | $13.51B | $15.72B | $16.43B | $14.19B | $21.48B | +12.3% |
Recent company headlines from major financial publishers.
If revenue meets expectations, profit and cash must still follow before the enlarged build creates enough value to change the valuation view.
This case strengthens if FY2027 revenue meets expectations and free cash flow improves despite the spending build. It weakens if higher spending keeps absorbing operating cash.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 7.9% | $343 | $356 | $371 | $390 | $414 |
| 8.9% | $308 | $317 | $327 | $338 | $353 |
| 9.9% | $282 | $288 | $295 | $303 | $312 |
| 10.9% | $261 | $266 | $270 | $276 | $282 |
| 11.9% | $244 | $248 | $251 | $255 | $259 |
Upcoming earnings date and setup when available.
Рейтинг, который имело опубликованное в каждом месяце издание исследования. Рейтинг сравнивает цену на дату анализа со справедливой стоимостью; он не показывает, оправдалась ли оценка.
| Год | янв. | февр. | март | апр. | май | июнь | июль | авг. | сент. | окт. | нояб. | дек. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |